JP Morgan Sec LLC

Willis Towers Watson plc 8.3

RNS Number : 5052L
J.P. Morgan Securities LLC
30 April 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

29 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 751,789  0.58

1,216,732  0.95

(2) Derivatives (other than options)

 565,550  0.44

674,060  0.52

(3)Optionsandagreementstopurchase/sell

 

 

Total

 1,317,339  1.02

1,890,792  1.47

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

USD

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

1,676

215,561

206

100

100

206

500

400

100

100

200

100

100

56

100

7

56

900

900

100

100

7

 

200

200

50

800

50

99,960

49,666

66

100

51

936

100

26

108

5

206

100

100

6

100

206

50

100

500

400

100

392

101

66

100

200

66

100

817

33

100

50

1,099

1,299

50

100

100

56

1,138

100

300

42,500

33

56

100

50

900

232

200

100

400

50

100

193

100

100

33

50

100

50

100

8,600

6,400

175.1379

 175.2600

 176.5800

 176.6000

 176.6100

 176.6400

 176.6500

 176.6800

 176.6900

 176.7400

 176.7500

 176.7950

 177.1500

 177.1900

 177.2200

 177.2400

 177.2650

 177.3100

 177.3150

 177.3600

 177.4300

 178.9200

 

 175.0000

 175.0400

 175.1084

 175.1763

 175.2155

 175.2600

 175.2601

 175.2700

 175.3784

 175.3990

 175.4410

 175.4800

 176.0894

 176.1641

 176.4750

 176.5800

 176.6000

 176.6100

 176.6157

 176.6350

 176.6400

 176.6414

 176.6450

 176.6500

 176.6800

 176.6900

 176.7015

 176.7295

 176.7337

 176.7400

 176.7500

 176.7645

 176.7950

 176.8856

 176.9231

 176.9300

 176.9315

 177.0103

 177.1069

 177.1492

 177.1500

 177.1861

 177.1900

 177.1971

 177.2200

 177.2300

 177.2375

 177.2563

 177.2650

 177.2900

 177.3069

 177.3150

 177.3159

 177.3350

 177.3600

 177.3775

 177.3789

 177.4300

 177.4455

 177.4456

 177.4576

 177.5070

 177.6405

 177.6817

 177.7859

 177.8522

 178.0900

 178.0917

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

  (USD)

(Note 5)

Equity Swap

Sale

900

177.3150

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

30 April 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBBLFXBZLZBBQ